BLIS Technologies (NZSE:BLT) Days Sales Outstanding : 33.77 (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies Days Sales Outstanding?

BLIS Technologies's average Accounts Receivable for the six months ended in Mar. 2024 was NZ$1.15 Mil. BLIS Technologies's Revenue for the six months ended in Mar. 2024 was NZ$6.19 Mil. Hence, BLIS Technologies's Days Sales Outstanding for the six months ended in Mar. 2024 was 33.77.

The historical rank and industry rank for BLIS Technologies's Days Sales Outstanding or its related term are showing as below:

NZSE:BLT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.06 Med: 59.81 Max: 67.21
Current: 36.06

During the past 13 years, BLIS Technologies's highest Days Sales Outstanding was 67.21. The lowest was 36.06. And the median was 59.81.

NZSE:BLT's Days Sales Outstanding is ranked better than
80.56% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs NZSE:BLT: 36.06

BLIS Technologies's Days Sales Outstanding increased from Mar. 2023 (31.50) to Mar. 2024 (33.77).

BLIS Technologies Days Sales Outstanding Historical Data

The historical data trend for BLIS Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies Days Sales Outstanding Chart

BLIS Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

67.21

53.38

65.62

57.53

47.75

BLIS Technologies Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															51.54	46.84	31.50	51.94	33.77

Competitive Comparison of BLIS Technologies's Days Sales Outstanding

For the Biotechnology subindustry, BLIS Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BLIS Technologies's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's Days Sales Outstanding falls into.

BLIS Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BLIS Technologies's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (1.448	+	1.295)	/	2 )	/	10.484	*	365
=	1.3715					/	10.484	*	365
=	47.75

BLIS Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0.996	+	1.295)	/	2 )	/	6.19	*	365 / 2
=	1.1455					/	6.19	*	365 / 2
=	33.77

BLIS Technologies (NZSE:BLT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

BLIS Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

BLIS Technologies (NZSE:BLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016

Website

https://www.blis.co.nz

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).